Cell-to-Cell Communication and Vascular Dementia

Microcirculation

Volumn 19, Issue 5, 2012, Pages 461-467

  Dietrich, Hans H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; CADASIL; Cell to cell communication; Cerebral microcirculation; Dementia; Neurovascular unit; Tauopathy

Indexed keywords

BRAIN BLOOD FLOW; CARDIOVASCULAR RISK; CELL COMMUNICATION; CELL TO CELL COMMUNICATION; DISEASE COURSE; HUMAN; MEDICAL LITERATURE; MICROCIRCULATION; MICROVASCULARIZATION; MULTIINFARCT DEMENTIA; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVOUS SYSTEM PARAMETERS; NEUROVASCULAR UNIT; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADULT; ANIMALS; CELL COMMUNICATION; DEMENTIA, VASCULAR; HUMANS; MODELS, CARDIOVASCULAR;

ANIMALIA;

EID: 84863740000     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2012.00175.x     Document Type: Review

References (81)

1. Altman R, Rutledge JC. The vascular contribution to Alzheimer's disease [Review]. Clin Sci 119: 407-421, 2010.
2. Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin Anat 8: 429-431, 1995.
3. Ames A, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral Ischemia II. The no-reflow phenomenon. Am J Pathol 52: 437-453, 1968.
4. Bennett MR, Farnell L, Gibson WG. Origins of blood volume change due to glutamatergic synaptic activity at astrocytes abutting on arteriolar smooth muscle cells. J Theor Biol 250: 172-185, 2008.
5. Brennan-Krohn T, Salloway S, Correia S, Dong M, De La Monte SM. Glial Vascular Degeneration in CADASIL. J Alzheimers Dis 21: 1393-1402, 2010.
6. Broe M, Kril J, Halliday GM. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 127: 2214-2220, 2004.
7. Dietrich HH, Ellsworth ML, Sprague RS, Dacey RG Jr. Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol 278: H1294-H1298, 2000.
8. Dietrich HH, Reese RL, Dacey RG Jr. Bradykinin B1 and B2 induced vasomotor responses and hypoxia in isolated rat cerebral arterioles. FASEB Journal 13: p, A21, 1999.
9. Dietrich HH, Reese RL, Dacey RG Jr., Tong JX. Hypoxia and EDHF inhibition attenuate bradykinin induced vasomotor responses in isolated rat cerebral arterioles. Society for Neuroscience Abstracts 25: 2200, 1999.
10. Dietrich HH, Xiang C, Dacey RG Jr. A method to study astrocyte to cerebro-arteriolar communication. Neuroscience Meeting Planner, Society for Neuroscience online Program Number168.16: 2007.
11. Dumanchin C, Camuzat A, Campion D, Verpillat P, Hannequin D, Dubois B, Saugier-Veber P, Martin C, Penet C, Charbonnier F, Agid Y, Frebourg T, Brice A. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and Parkinsonism. Hum Mol Genet 7: 1825-1829, 1998.
12. Eftekhari A, Mathiassen ON, Buus NH, Gotzsche O, Mulvany MJ, Christensen KL. Disproportionally impaired microvascular structure in essential hypertension. J Hypertens 29: 896-905, 2011.
13. Fellin T, Carmignoto G. Neurone-to-astrocyte signalling in the brain represents a distinct multifunctional unit. J Physiol 559: 3-15, 2004.
14. Filosa JA, Bonev AD, Nelson MT. Calcium dynamics in cortical astrocytes and arterioles during neurovascular coupling. Circ Res 95: e73-e81, 2004.
15. Filosa JA, Bonev AD, Straub SV, Meredith AL, Wilkerson MK, Aldrich RW, Nelson MT. Local potassium signaling couples neuronal activity to vasodilation in the brain. Nat Neurosci 9: 1397-1403, 2006.
16. Fukuda H, Sawa Y, Kadoba K, Taniguchi K, Shimazaki Y, Matsuda H. Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury. Circulation 92(Suppl.): 413-416, 1995.
17. Fukushima T, Nakamura A, Iwakami N, Nakada Y, Hattori H, Hoki S, Yamaguchi H, Nakagawa M, Terashima N, Narita H. T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice. Biochem Biophys Res Commun 407: 730-734, 2011.
18. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
19. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ, Nithipatikom K, Campbell WB, Harder DR. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 87: 60-65, 2000.
20. Gordon GR, Mulligan SJ, MacVicar BA. Astrocyte control of the cerebrovasculature. Glia 55: 1214-1221, 2007.
21. Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S. Vascular contributions to cognitive impairment and dementia. Stroke 42: 2672-2713, 2011.
22. Greenberg J, Hand PJ, Sylvestro A, Reivich M. Localized metabolic-flow couple during functional activity. Acta Neurol Scand Suppl 72: 12-13, 1979.
23. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 304: 207-209, 1974.
24. Hayashi T, Abe K, Suzuki H, Itoyama Y. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 28: 2039-2044, 1997.
25. Haydon PG, Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86: 1009-1031, 2006.
26. Horiuchi T, Dietrich HH, Hongo K, Dacey RG Jr. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles. Stroke 34: 1473-1478, 2003.
27. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci 10: 1369-1376, 2007.
28. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 61: 866-879, 1987.
29. Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 109: 813-836, 2002.
30. Jones EL, Kalaria RN, Sharp SI, O'Brien JT, Francis PT, Ballard CG. Genetic associations of autopsy-confirmed vascular dementia subtypes. Dement Geriatr Cogn Disord 31: 247-253, 2011.
31. Joutel A, Monet-Lepretre M, Gosele C, Baron-Menguy C, Hammes A, Schmidt S, Lemaire-Carrette B, Domenga V, Schedl A, Lacombe P, Hubner N. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest 120: 433-445, 2010.
32. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, Cruaud C, Maciazek J, Weissenbach J, Bousser MG, Bach JF, Tournier-Lasserve E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 350: 1511-1515, 1997.
33. Kersaitis C, Halliday GM, Kril JJ. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol 108: 515-523, 2004.
34. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95: 189-197, 2000.
35. King DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav Brain Res 103: 145-162, 1999.
36. Kobayashi N, DeLano FA, Schmid-Schonbein GW. Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 25: 2114-2121, 2005.
37. Kulik TB, Aronhime SN, Echeverry G, Beylin A, Winn HR. The relationship between oxygen and adenosine in astrocytic cultures. Glia 58: 1335-1344, 2010.
38. Kurjiaka DT, Segal SS. Conducted vasodilation elevates flow in arteriole networks of hamster striated muscle. Am J Physiol 269: H1723-H1728, 1995.
39. Lacombe P, Oligo C, Domenga V, Tournier-Lasserve E, Joutel A. Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke 36: 1053-1058, 2005.
40. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML. Autocrine VEGF signaling is required for vascular homeostasis. Cell 130: 691-703, 2007.
41. Li A, Xi Q, Umstot ES, Bellner L, Schwartzman ML, Jaggar JH, Leffler CW. Astrocyte-derived CO is a diffusible messenger that mediates glutamate-induced cerebral arteriolar dilation by activating smooth muscle Cell KCa channels. Circ Res 102: 234-241, 2008.
42. Lin Y, Duling BR. Vulnerability of conducted vasomotor response to ischemia. Am J Physiol 267: H2363-H2370, 1994.
43. Liu X, Li C, Falck JR, Roman RJ, Harder DR, Koehler RC. Interaction of nitric oxide, 20-HETE, and EETs during functional hyperemia in whisker barrel cortex. Am J Physiol Heart Circ Physiol 295: H619-H631, 2008.
44. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5' enhancer. Circ Res 77: 638-643, 1995.
45. Lovick TA, Brown LA, Key BJ. Neuronal activity-related coupling in cortical arterioles: involvement of astrocyte-derived factors. Exp Physiol 90: 131-140, 2004.
46. Martinez AD, Saez JC. Regulation of astrocyte gap junctions by hypoxia-reoxygenation. Brain Res Brain Res Rev 32: 250-258, 2000.
47. Mason RB, Pluta RM, Walbridge S, Wink DA, Oldfield EH, Boock RJ. Production of reactive oxygen species after reperfusion in vitro and in vivo: protective effect of nitric oxide. J Neurosurg 93: 99-107, 2000.
48. Metea MR, Newman EA. Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling. J Neurosci 26: 2862-2870, 2006.
49. Molina CA, varez-Sabin J. Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis 27(Suppl. 1): 162-167, 2009.
50. Moore AW, Bearden SE, Segal SS. Regional activation of rapid onset vasodilatation in mouse skeletal muscle: regulation through α-adrenoreceptors. J Physiol 588: 3321-3331, 2010.
51. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 67: 181-198, 2010.
52. Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 431: 195-199, 2004.
53. Ngai AC, Nguyen TS, Meno JR, Britz GW. Postischemic augmentation of conducted dilation in cerebral arterioles. Stroke 38: 124-130, 2007.
54. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST. Vascular cognitive impairment. Lancet Neurol 2: 89-98, 2003.
55. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 2: 161-192, 1990.
56. Queiroz G, Meyer DK, Meyer A, Starke K, von Kügelgen I. A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience 91: 1171-1181, 1999.
57. Reynolds JM, McDonagh PF. Early in reperfusion, leukocytes alter perfused capillarity and vascular resistance. Am J Physiol 256: H982-H989, 1989.
58. Ronnemaa E, Zethelius B, Lannfelt L, Kilander L. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 31: 460-466, 2011.
59. Roy CS, Sherrington CS. On the regulation of the blood-supply of the brain. J Physiol 11: 85-158, 1890.
60. Ruchoux MM, Domenga V, Brulin P, Maciazek J, Limol S, Tournier-Lasserve E, Joutel A. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol 162: 329-342, 2003.
61. Schmidt-Schönbein GW. Mechnism of granulocyte-capillary-plugging. Prog Appl Microcirc 12: 223-230, 1987.
62. Shima DT, Adamis AP, Ferrara N, Yeo KT, Yeo TK, Allende R, Folkman J, D'Amore PA. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med 1: 182-193, 1995.
63. Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M. Signaling at the gliovascular interface. J Neurosci 23: 9254-9262, 2003.
64. Spuch C, Antequera D, Portero A, Orive G, Hernandez RM, Molina JA, Bermejo-Pareja F, Pedraz JL, Carro E. The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. Biomaterials 31: 5608-5618, 2010.
65. Szpak GM, Lewandowska E, Wierzba-Bobrowicz T, Bertrand E, Pasennik E, Mendel T, Stepien T, Leszczynska A, Rafalowska J. Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies. Folia Neuropathol 45: 192-204, 2007.
66. Takano T, Tian GF, Peng W, Lou N, Libionka W, Han X, Nedergaard M. Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 9: 260-267, 2006.
67. The Stroke Progress Review Group. Stroke Priorities for the 21st Century., 2002.
68. Tran CH, Welsh DG. The differential hypothesis: a provocative rationalization of the conducted vasomotor response. Microcirculation 17: 226-236, 2010.
69. van den Oever I, Raterman HG, Nurmohamed MT, Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm 2010: Article ID 792393, 2010.
70. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34: 1126-1129, 2003.
71. Vermeer SE, Longstreth WT Jr., Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 6: 611-619, 2007.
72. Viswanathan A, Godin O, Jouvent E, O'Sullivan M, Gschwendtner A, Peters N, Duering M, Guichard JP, Holtmannspotter M, Dufouil C, Pachai C, Bousser MG, Dichgans M, Chabriat H. Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL. Neurobiol Aging 31: 1629-1636, 2010.
73. Wang WZ, Anderson G, Fleming JT, Peter FW, Franken RJ, Acland RD, Barker J. Lack of nitric oxide contributes to vasospasm during ischemia/reperfusion injury. Plast Reconstr Surg 99: 1099-1108, 1997.
74. Winkler E, Bell R, Zlokovic B. Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. Mol Neurodegener 5: 32, 2010.
75. Winn HR, Rubio R, Berne RM. Brain adenosine concentration during hypoxia in rats. Am J Physiol 241: H235-H242, 1981.
76. Xu HL, Koenig HM, Ye S, Feinstein DL, Pelligrino DA. Influence of the glia limitans on pial arteriolar relaxation in the rat. Am J Physiol Heart Circ Physiol 287: H331-H339, 2004.
77. Xu HL, Pelligrino DA. ATP release and hydrolysis contribute to rat pial arteriolar dilatation elicited by neuronal activation. Exp Physiol 92: 647-651, 2007.
78. Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 15: 1031-1037, 2009.
79. Zacchigna S, Lambrechts D, Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci 9: 169-181, 2008.
80. Zhang YW, Morita I, Nishida M, Murota SI. Involvement of tyrosine kinase in the hypoxia/reoxygenation-induced gap junctional intercellular communication abnormality in cultured human umbilical vein endothelial cells. J Cell Physiol 180: 305-313, 1999.
81. Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T, Carmignoto G. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6: 43-50, 2003.